DeDora Capital’s HCA Healthcare HCA Stock Holding History

DeDora Capital’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-55	Closed	-$14K	–	224
2022 Q1	$14K	Buy	+55	New	+$13.8K	0.01%	273

Other funds holding HCA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

DeDora Capital's HCA Position: Q2 2022 in Review

DeDora Capital sold out of HCA Healthcare (HCA) in Q2 2022, closing a stake of 55 shares — an estimated $14K sold.

DeDora Capital first reported a position in HCA in Q1 2022 and held it in 1 quarter. The position peaked at $14K in Q1 2022. 883 funds tracked by Wall St. Rank hold HCA as of Q2 2022.

DeDora Capital reported no remaining HCA Healthcare position as of Q2 2022 after selling out during the quarter.
DeDora Capital sold 55 HCA Healthcare shares in Q2 2022, an estimated $14K.
DeDora Capital first reported a position in HCA Healthcare in Q1 2022 and held it in 1 quarter.
DeDora Capital's HCA Healthcare position peaked at $14K in Q1 2022.
883 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2022.

Based on DeDora Capital's 13F filing for Q2 2022, filed 27 Jul 2022.